Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Implementation of programmes for dialysis, transplantation and renal-disease screening in developing countries is a complex and challenging task. Here, the authors provide the perspective of their efforts to implement renal care in Haiti. They focus on the importance of collaboration, education and partnership building, rather than on technological issues.
The discovery and clinical development of new drugs—particularly therapies for kidney diseases—is a lengthy and costly process. Here, the authors discuss the need for closer collaboration between academia, industry and regulatory authorities to enable novel, efficient strategies for preclinical and clinical drug development. They also describe the current Japanese framework implemented to facilitate such collaboration.
